Endocrinology

Researchers sought to determine whether patients with type 2 diabetes and obesity experience continued type 2 diabetes remission.

In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the multidisciplinary approach to managing people with diabetes, the importance of diabetes self-care and...

Researchers compared the effects of once-weekly semaglutide (2.4 mg) with a placebo during a 52-week period in patients with HFpEF and a BMI of 30 or higher.

Tirzepatide is now approved for a new indication. The dual GIP/GLP-1 agonist was previously approved for treating type 2 diabetes in May 2022.

The US Preventive Task Force (USPSTF) released its updated recommendations for screening children and adolescents for lipid disorders.

This COVID-19 roundup includes coverage on the FDA-approved oral antiviral treatment for adults with mild-to-moderate COVID-19, how antidepressant medication may lower the incidence of COVID-19, a study...

The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.

Based on recent scientific knowledge, the American Diabetes Association (ADA) released a set of updates including recommendations for the detection and management of nonalcoholic fatty liver disease in...

Researchers evaluated the effectiveness of parathyroidectomy to manage kidney function in adults with hyperparathyroidism.